News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199 Results
Type
Article (19)
Press Release (180)
Section
Business (60)
Deals (13)
Drug Development (33)
FDA (8)
Job Trends (2)
News (80)
Policy (5)
Tag
Alliances (15)
Antibody-drug conjugate (ADC) (2)
Approvals (8)
Best Places to Work (2)
Bispecific (1)
Cancer (17)
Cell therapy (1)
Clinical research (35)
Collaboration (4)
COVID-19 (5)
Data (8)
Earnings (17)
Events (49)
FDA (10)
Funding (1)
Government (1)
Healthcare (4)
Immuno-oncology (1)
Infectious disease (5)
IPO (6)
Legal (2)
Mergers & acquisitions (6)
NextGen: Class of 2026 (2)
Patient selection (2)
People (16)
Phase 1 (30)
Phase 2 (23)
Phase 3 (8)
Pipeline (9)
Preclinical (2)
Real estate (1)
Regulatory (6)
Research institute (1)
Startups (5)
Date
Last 7 days (3)
Last 30 days (6)
Last 365 days (23)
2026 (22)
2025 (25)
2024 (14)
2023 (13)
2022 (33)
2021 (41)
2020 (8)
2019 (7)
2018 (4)
2016 (2)
2015 (3)
2014 (4)
2013 (3)
2012 (1)
2011 (1)
2010 (1)
Location
Asia (131)
California (52)
China (36)
Europe (17)
New Jersey (1)
Northern California (1)
Pennsylvania (1)
Southern California (51)
United States (52)
199 Results for "adagene".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
October 27, 2026
·
4 min read
Press Releases
Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal Cancer
November 17, 2026
·
10 min read
Press Releases
Adagene to Participate in H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference
October 14, 2026
·
4 min read
Press Releases
City of Hope and Adagene Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal Cancer
November 17, 2026
·
6 min read
Press Releases
Adagene Announces First Patient Dosed in Phase 1 Study of ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
November 19, 2026
·
6 min read
Press Releases
Adagene to Participate in Three Upcoming September 2026 Investor Conferences
August 20, 2026
·
4 min read
Press Releases
Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
November 9, 2026
·
6 min read
Press Releases
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
September 9, 2026
·
4 min read
Press Releases
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
August 12, 2026
·
19 min read
Press Releases
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer
October 28, 2026
·
5 min read
1 of 20
Next